Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities
Antioxidants · 15.06.2025 · 14 (6) · 735
DOI: 10.3390/antiox14060735 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 15.06.2025. Verfasst von Meimei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Technology, Dongguan University of Technology, Dongguan 523808, China. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 438 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong basic and applied basic research foundation, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
As two pivotal regulatory factors in cancer biology, oxidative stress and inflammation interact dynamically through complex network mechanisms to influence tumor initiation, progression, and treatment resistance. Oxidative stress induces genomic instability, oncogenic signaling activation, and tumor microenvironment (TME) remodeling via the abnormal accumulation of reactive oxygen species (ROS) or reactive nitrogen species (RNS). Conversely, inflammation sustains malignant phenotypes by releasing pro-inflammatory cytokines and chemokines and promoting immune cell infiltration. These processes create a vicious cycle via positive feedback loops whereby oxidative stress initiates inflammatory signaling, while the inflammatory milieu further amplifies ROS/RNS production, collectively promoting proliferation, migration, angiogenesis, drug resistance, and immune evasion in tumor cells. Moreover, their crosstalk modulates DNA damage repair, metabolic reprogramming, and drug efflux pump activity, significantly impacting the sensitivity of cancer cells to chemotherapy, radiotherapy, and targeted therapies. This review systematically discusses these advances and the molecular mechanisms underlying the interplay between oxidative stress and inflammation in cancer biology. It also explores their potential as diagnostic biomarkers and prognostic indicators and highlights novel therapeutic strategies targeting the oxidative stress–inflammation axis. The goal is to provide a theoretical framework and translational roadmap for developing synergistic anti-tumor therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life and Health Technology, Dongguan University of Technology, Dongguan 523808, China.
- Department of Gastroenterology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
ORCID-Profile: Biao Xie
Förderung
- National Natural Science Foundation of China
- Guangdong basic and applied basic research foundation
- Shenzhen Science and Technology Program
Zitieren
APA
Wang, M., Xiao, Y., Miao, J., Zhang, X., Liu, M., Zhu, L., Liu, H., Shen, X., Wang, J., Xie, B., & Wang, D. (2025). Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities. Antioxidants, 14(6), 735. https://doi.org/10.3390/antiox14060735
Vancouver
Wang M, Xiao Y, Miao J, Zhang X, Liu M, Zhu L, et al. Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities. Antioxidants. 2025;14(6):735. doi:10.3390/antiox14060735
BibTeX
@article{Wang2025,
author = {Wang, Meimei and Xiao, Yaping and Miao, Jie and Zhang, Xin and Liu, Meng and Zhu, Longchao and Liu, Hongxin and Shen, Xiaoyan and Wang, Jihui and Xie, Biao and Wang, Di},
title = {Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {6},
pages = {735},
doi = {10.3390/antiox14060735}
}
EUVIMED